The Effects of an Exercise Program on Anxiety Levels and Metabolic Functions in Patients With Anxiety Disorders

Biological Research for Nursing

Volumn 19, Issue 3, 2017, Pages 258-268

  Ma, Wei Fen ^a,b   Wu, Po Lun ^b   Su, Chia Hsien ^a,b   Yang, Tzu Ching ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

anxiety; community; exercise program; mental illness; metabolic control function

Indexed keywords

ADULT; AGED; ANXIETY DISORDERS; COMPLICATION; CONTROLLED STUDY; EXERCISE; FEMALE; HUMAN; KINESIOTHERAPY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; TAIWAN;

ADULT; AGED; ANXIETY DISORDERS; EXERCISE; EXERCISE THERAPY; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TAIWAN;

EID: 85018737470     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800416672581     Document Type: Article

References (55)

1. Albert U., Aguglia A., Chiarle A., Bogetto F., Maina G., (2013). Metabolic syndrome and obsessive–compulsive disorder: A naturalistic Italian study. General Hospital Psychiatry, 35, 154–159.
2. Alberti K. G. M. M., Zimmet P., Shaw J., (2006). Metabolic syndrome—A new world-wide definition. A consensus statement from the International Diabetes Federation. Diabetic Medicine, 23, 469–480.
3. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR (4th Rev. ed.). Washington, DC: Author.
4. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-V (5th ed.). Washington, DC: Author.
5. Amiri P., Hosseinpanah F., Rambod M., Montazeri A., Azizi F., (2010). Metabolic syndrome predicts poor health-related quality of life in women but not in men: Tehran Lipid and Glucose Study. Journal of Women’s Health, 19, 1201–1207.
6. Barr W. G., (1990). Uric acid. In Walker H. K., Hall W. D., Hurst J. W., (Eds.), Clinical methods: The history, physical, and laboratory examinations (3rd ed., pp. 770–772). Boston, MA: Butterworths.
7. Brunero S., Lamont S., (2009). Systematic screening for metabolic syndrome in consumers with severe mental illness. International Journal of Mental Health Nursing, 18, 144–150.
8. Brunero S., Lamont S., Fairbrother G., (2009). Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia. Archives of Psychiatric Nursing, 23, 261–268. doi:10.1016/j.apnu.2008.06.007
9. Butnoriene J., Bunevicius A., Norkus A., Bunevicius R., (2014). Depression but not anxiety is associated with metabolic syndrome in primary care based community sample. Psychoneuroendocrinology, 40, 269–276.
10. Campbell Burton C., Murray J., Holmes J., Astin F., Greenwood D., Knapp P., (2013). Frequency of anxiety after stroke: A systematic review and meta-analysis of observational studies. International Journal of Stroke, 8, 545–559.
11. Carroll D., Phillips A. C., Thomas G. N., Gale C. R., Deary I., Batty G. D., (2009). Generalized anxiety disorder is associated with metabolic syndrome in the Vietnam Experience study. Biological Psychiatry, 66, 91–93. doi:10.1016/j.biopsych.2009.02.020
12. Department of Health, Taiwan, Republic of China. (2014). Health and national health insurance annual statistics information service. Retrieved June 5, 2015, from http://www.nhi.gov.tw/webdata/webdata.aspx?menu=17&menu_id=1023&webdata_id=3520
13. Dhananjai S., Tiwari S., Dutt K., Kumar R., (2013). Reducing psychological distress and obesity through Yoga practice. International Journal of Yoga, 6, 66.
14. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (2001). Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Journal of the American Medical Association, 285, 2486.
15. First M. B., Spitzer R. L., Gibbon M., Williams J. B. W., (2002). Structured clinical interview for DSM-IV-TR Axis I disorders, research version, patient edition (SCID-I/P). New York, NY: Biometrics Research, New York State Psychiatric Institute.
16. Garson G. D., (2013). Longitudinal analysis (Statistical Associates Blue Book Series, no. 39; Kindle Ed). Asheboro, NC: Statistical Associates Publishers.
17. Graham N., Smith D. J., (2016). Comorbidity of depression and anxiety disorders in patients with hypertension. Journal of Hypertension, 34, 397–398.
18. Grundy S. M., Hansen B., Smith S. C., Cleeman J. I., Kahn R. A., (2004). Clinical management of metabolic syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issue related to management. Circulation, 109, 551–556.
19. Henderson D. C., Cagliero E., Copeland P. M., Borba C. P., Evins E., Hayden D., …Schoenfeld D., (2005). Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: A frequently sampled intravenous glucose tolerance test and minimal model analysis. Archives of General Psychiatry, 62, 19–28.
20. Huang K. L., Su T. P., Chen T. J., Chou Y. H., Bai Y. M., (2009). Comorbidity of cardiovascular diseases with mood and anxiety disorder: A population based 4-year study. Psychiatry and Clinical Neurosciences, 63, 401–409.
21. Hung C. I., Liu C. Y., Hsiao M. C., Yu N. W., Chu C. L., (2014). Metabolic syndrome among psychiatric outpatients with mood and anxiety disorders. BMC Psychiatry, 14, 1.
22. International Diabetes Federation. (2005). The IDF consensus worldwide definition of the metabolic syndrome. Brussels, Belgium: Author.
23. Jayakody K., Gunadasa S., Hosker C., (2013). Exercise for anxiety disorders: Systematic review. British Journal of Sports Medicine, 48, 187–196.
24. Kario K., (2010). Morning surge in blood pressure and cardiovascular risk evidence and perspectives. Hypertension, 56, 765–773.
25. Lemche A. V., Chaban O. S., Lemche E., (2016). Trait anxiety but not state anxiety level associates with biomarkers for hypertension in the metabolic syndrome. Psychophysiology, 53, 914–920.
26. Lin K. M., Chiou J. Y., Ko S. H., Tan J. Y., Huang C. N., Liao W. C., (2015). Modifiable lifestyle behaviors are associated with metabolic syndrome in a Taiwanese population. Journal of Nursing Scholarship, 47, 487–495.
27. Lin K. P., Liang T. L., Liao I. C., Tsay S. L., (2014). Associations among depression, obesity, and metabolic syndrome in young adult females. Biological Research for Nursing, 16, 327–334.
28. Ma W. F., Chiang L. C., Yen W. J., Huang L. C., Tsai T. W., (2011). 3-month physical activity checklist: Development and validation with Taiwanese adults with mental illness. International Journal of Nursing Studies, 48, 1517–1520.
29. Ma W. F., Huang X. Y., Chang H. J., Yen W. J., Lee S., (2010). Impact of Taiwanese culture on beliefs about expressing anxiety and engaging in physical activity: A discursive analysis of the literature. Journal of Clinical Nursing, 19, 969–977.
30. Ma W. F., Liu Y. C., Chen Y. F., Lane H. Y., Lai T. J., Huang L. H., (2013). Evaluation of psychometric properties of the Chinese Mandarin version State-Trait Anxiety Inventory Y form in Taiwanese outpatients with anxiety disorders. Journal of Psychiatric and Mental Health Nursing, 20, 499–507.
31. Ma W. F., Lane H. Y., Laffrey S. C., (2008). A model testing factors that influence physical activity for Taiwanese adults with anxiety. Research in Nursing & Health, 31, 476–489.
32. Malhotra N., Kulhara P., Chakrabarti S., Grover S., (2013). A prospective, longitudinal study of metabolic syndrome in patients with bipolar disorder and schizophrenia. Journal of Affective Disorders, 150, 653–658.
33. Matthews D. R., Hosker J. P., Rudenski A. S., Naylor B. A., Treacher D. F., Turner R. C., (1985). Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412–419.
34. Meyer J. M., Stahl S. M., (2009). The metabolic syndrome and schizophrenia. Acta Psychiatrica Scandinavica, 119, 4–14.
35. Opie L. H., (2007). Metabolic syndrome. Circulation, 115, e32–e35.
36. Özpelit M. E., Özpelit E., Doğan N. B., Pekel N., Ozyurtlu F., Yılmaz A., …Ercan E., (2015). Impact of anxiety level on circadian rhythm of blood pressure in hypertensive patients. International Journal of Clinical and Experimental Medicine, 8, 16252–16258.
37. Pearsall R., Smith D. J., Pelosi A., Geddes J., (2014). Exercise therapy in adults with serious mental illness: A systematic review and meta-analysis. BMC Psychiatry, 14, 1.
38. Pedersen B. K., Saltin B., (2015). Exercise as medicine—Evidence for prescribing exercise as therapy in 26 different chronic diseases. Scandinavian Journal of Medicine & Science in Sports, 25, 1–72.
39. Pender N. J., Murdaugh C. L., Parsons M. A., (2006). Health promotion in nursing practice (5th ed.). Upper Saddle River, NJ: Prentice Hall.
40. Petruzzello S. J., Landers D. M., Hatfield B. D., Kubitz K. A., Salazar W., (1991). A meta-analysis on the anxiety-reducing effects of acute and chronic exercise. Sports Medicine, 11, 143–182.
41. Pires G. C., Rockett F. C., Salum G. A., Manfro G. G., Bosa V. L., (2015). Cardiovascular risk factors in children and adolescents with anxiety disorders and their association with disease severity. Nutrición Hospitalaria, 31, 269–277.
42. Puig J. G., Torres R. J., de Miguel E., Sánchez A., Bailén R., Banegas J. R., (2012). Uric acid excretion in healthy subjects: A nomogram to assess the mechanisms underlying purine metabolic disorders. Metabolism, 61, 512–518.
43. Sacks D. B., Arnold M., Bakris G. L., Bruns D. E., Horvath A. R., Kirkman M. S., …Nathan D. M., (2011). Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care, 34, e61–e99.
44. Smits J. A. J., Zvolensky M. J., (2006). Emotional vulnerability as a function of physical activity among individuals with panic disorder. Depression and Anxiety, 23, 102–106.
45. Spielberger C. D., (1966). Anxiety and behavior. New York, NY: Academic Press.
46. Spielberger C. D., (1983). Manual for the State-Trait Anxiety Inventory (Form Y). Menlo Park, CA: Mind Garden.
47. Teixeira R. B., Marins J. C. B., de Sá Junior A. R., de Carvalho C. J., da Silva Moura T. A., Lade C. G., …Palotás A., (2015). Improved cognitive, affective and anxiety measures in patients with chronic systemic disorders following structured physical activity. Diabetes and Vascular Disease Research, 12, 445–454.
48. van Reedt Dortland A. K., Vreeburg S. A., Giltay E. J., Licht C. M., Vogelzangs N., van Veen T., …Zitman F. G., (2013). The impact of stress systems and lifestyle on dyslipidemia and obesity in anxiety and depression. Psychoneuroendocrinology, 38, 209–218.
49. Walker S. N., Sechrist K. R., Pender N. J., (1987). The health-promoting lifestyle profile: Development and psychometric characteristics. Nursing Research, 36, 76–81. doi:10.1097/00006199-198703000-00002
50. Wei M. H., Lu C. M., (2005). Development of the short-form Chinese Health-promoting Lifestyle Profile. Journal of Health Education, 24, 25–45.
51. Wilson P. M., Rogers W. T., Rodgers W. M., Wild T. C., (2006). The psychological need satisfaction in exercise scale. Journal of Sport & Exercise Psychology, 28, 231–251
52. Wipfli B. M., Rethorst C. D., Landers D. M., (2008). The anxiolytic effects of exercise: A meta-analysis of randomized trials and dose–response analysis. Journal of Sport & Exercise Psychology, 30, 392–410.
53. Wolff E., Gaudlitz K., von Lindenberger B. L., Plag J., Heinz A., Ströhle A., (2011). Exercise and physical activity in mental disorders. European Archives of Psychiatry and Clinical Neuroscience, 261, 186–191.
54. World Health Organization. (2010). Global recommendations on physical activity for health. Geneva: Author. Retrieved from http://www.who.int/dietphysicalactivity/publications/9789241599979/en/
55. Zimmet P., Magliano D., Matsuzawa Y., Alberti G., Shaw J., (2005). The metabolic syndrome: A global public health problem and a new definition. Journal of Atherosclerosis and Thrombosis, 12, 295–300.